Published in Med Microbiol Immunol on May 15, 1979
Pseudorabies virus infection alters neuronal activity and connectivity in vitro. PLoS Pathog (2009) 1.05
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Bee and wasp venoms. Science (1972) 7.35
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Botulinum C2 toxin ADP-ribosylates actin. Nature (1986) 3.16
Borna disease: a persistent virus infection of the central nervous system. Prog Med Virol (1988) 2.83
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76
Genomic organization of Borna disease virus. Proc Natl Acad Sci U S A (1994) 2.74
[Sequence analysis of melittin from tryptic and peptic degradation products]. Hoppe Seylers Z Physiol Chem (1967) 2.72
Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J (1986) 2.62
Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc Natl Acad Sci U S A (1992) 2.44
Repetitive sequences in complete and defective genomes of Herpesvirus saimiri. J Virol (1975) 2.36
Borna disease virus genome transcribed and expressed in psychiatric patients. Nat Med (1995) 2.30
The challenge of biosimilars. Ann Oncol (2007) 2.28
The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer (1993) 2.23
Identification of a common antigen of herpes simplex virus bovine herpes mammillitis virus, and B virus. J Virol (1978) 2.16
Interleukin-6 is a prognostic factor in multiple myeloma. Blood (1991) 2.16
A viro-psycho-immunological disease-model of a subtype affective disorder. Pharmacopsychiatry (1998) 2.08
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood (1998) 1.90
Physicochemical properties of the DNA of herpes viruses. Biochim Biophys Acta (1972) 1.86
Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol (2001) 1.85
Clostridial neurotoxins: handling and action at the cellular and molecular level. Curr Top Microbiol Immunol (1986) 1.84
First isolates of infectious human Borna disease virus from patients with mood disorders. Mol Psychiatry (1996) 1.83
Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B. Mol Microbiol (1995) 1.81
A post-docking role for synaptobrevin in synaptic vesicle fusion. Neuron (1994) 1.78
A simple method for measuring red cell deformability in models of the microcirculation. Blut (1973) 1.75
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74
Sequence conservation in field and experimental isolates of Borna disease virus. J Virol (1994) 1.67
Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers. Virus Genes (1999) 1.65
Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet (1997) 1.62
Persistent, tolerant or subacute infection in Borna disease virus-infected rats. J Gen Virol (1983) 1.62
Cerebrovascular tone rather than intracranial pressure determines the effective downstream pressure of the cerebral circulation in the absence of intracranial hypertension. J Neurosurg Anesthesiol (2000) 1.61
Clp-mediated proteolysis in Gram-positive bacteria is autoregulated by the stability of a repressor. EMBO J (2001) 1.61
Borna disease--neuropathology and pathogenesis. Curr Top Microbiol Immunol (1995) 1.59
Borna disease virus-specific antibodies in patients with HIV infection and with mental disorders. Lancet (1988) 1.57
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.47
Biochemistry and pharmacology of the crotoxin complex. Biochemical analysis of crotapotin and the basic Crotalus phospholipase A. Eur J Biochem (1974) 1.46
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer (2010) 1.46
Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia (2008) 1.42
Immunologic and genetic relationship between herpes simplex virus and bovine herpes mammillitis virus. Intervirology (1974) 1.41
[Modifications of amino groups and tryptophan in melittin as an aid to recognition of structure-activity relationships]. Hoppe Seylers Z Physiol Chem (1970) 1.40
[MCD-peptide from bee venom: isolation, biochemical and pharmacolgical properties]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 1.40
Interferon-alpha treatment in multiple myeloma: meta-analysis of 30 randomised trials among 3948 patients. Ann Oncol (2000) 1.39
Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study. Ann Oncol (2009) 1.39
Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1. J Virol (1988) 1.34
Borna disease in ostriches. Vet Rec (1993) 1.34
Studies on the relatedness of herpes viruses through DNA-RNA hybridization. Biochim Biophys Acta (1972) 1.31
Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol (2012) 1.31
Immunoprecipitation of herpes simplex virus type 1 antigens with different antisera and human cerebrospinal fluids. Arch Virol (1977) 1.30
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia (2009) 1.29
[Borna virus infection (Borna disease) in naturally and experimentally infected animals: its significance for research and practice]. Tierarztl Prax (1985) 1.29
Behavior alterations in tree shrews (Tupaia glis, Diard 1820) induced by Borna disease virus. Med Microbiol Immunol (1978) 1.29
Analysis of herpes simplex virus type 1 antigens exposed on the surface of infected tissue culture cells. Virology (1978) 1.28
Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer (1994) 1.25
Apamin. Pharmacol Ther (1984) 1.24
A sensitive and specific plate test for the quantitation of phospholipases. Anal Biochem (1972) 1.23
The characterization of Varicella-zoster virus DNA. J Gen Virol (1972) 1.23
Adaptation of Borna disease virus to the mouse. J Gen Virol (1984) 1.23
Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion. Leukemia (2006) 1.22
Human infections with Borna disease virus: seroprevalence in patients with chronic diseases and healthy individuals. J Med Virol (1992) 1.22
Increase of virus yields and releases of Borna disease virus from persistently infected cells. Virus Res (1985) 1.20
Natural Borna disease in domestic animals others than horses and sheep. Zentralbl Veterinarmed B (1993) 1.18
The ionic properties of the filamentous bacteriophages Pf1 and fd. J Biol Chem (1986) 1.18
The renal handling of polybasic drugs. 1. Gentamicin and aprotinin in intact animals. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.18
[Autoimmune phenomena in D-penicillamine therapy]. Acta Med Austriaca (1975) 1.17
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement. Leukemia (2011) 1.17
Isolation and characterization of a 14500 molecular weight protein from brains and tissue cultures persistently infected with borna disease virus. J Gen Virol (1985) 1.17
Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur J Hum Genet (2000) 1.17
Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology (1993) 1.16
Expression of vesicle-associated membrane protein 2 (VAMP-2)/synaptobrevin II and cellubrevin in rat skeletal muscle and in a muscle cell line. Biochem J (1994) 1.16
Learning deficiencies in Borna disease virus-infected but clinically healthy rats. Biol Psychiatry (1989) 1.15
Sequence characterization of human Borna disease virus. Virus Res (1996) 1.15
Structural changes during development in bovine fetal epiphyseal cartilage. Coll Relat Res (1981) 1.15
Inhibition of herpes virus-induced cell fusion by concanavalin A, antisera, and 2-deoxy-D-glucose. J Virol (1974) 1.14
Lead and other metals can substitute for Ca2+ in calmodulin. Arch Toxicol (1983) 1.14
Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone (1996) 1.14
Borna disease in rhesus monkeys as a models for uveo-cerebral symptoms. J Med Virol (1981) 1.13
[Surface structure of the human placenta in the scanning electron microscope]. Arch Gynakol (1971) 1.12
Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis. Cell Death Differ (2006) 1.11
A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin. Toxicon (1991) 1.10
The tetanus toxin light chain inhibits exocytosis. FEBS Lett (1989) 1.09
[Anticoagulants in the radiotherapy of genital carcinomas in women. I. Squamous cell carcinoma]. Med Welt (1968) 1.09
Gangliosides in nervous tissue cultures and binding of 125I-labelled tetanus toxin, a neuronal marker. J Neurochem (1977) 1.08
Humoral immunodeficiency to bacterial antigens in patients with juvenile onset diabetes mellitus. Diabetologia (1976) 1.08
Fluorosugars inhibit biological properties of different enveloped viruses. J Virol (1976) 1.06
A new inactivated tissue culture rabies vaccine for use in man. Evaluation of PCEC-vaccine by laboratory tests. J Biol Stand (1984) 1.05
Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis. Ann Hematol (2010) 1.04
[Ultrastructure of the luminal surface of Fallopian tube in the scanning electron microscope]. Arch Gynakol (1972) 1.04
Analysis of bovine cytomegalovirus genome structure: cloning and mapping of the monomeric polyrepetitive DNA unit, and comparison of European and American strains. J Gen Virol (1985) 1.04
Bovine cytomegaloviruses: identification and differential properties. J Gen Virol (1984) 1.04
Borna disease virus-specific circulating immune complexes, antigenemia, and free antibodies--the key marker triplet determining infection and prevailing in severe mood disorders. Mol Psychiatry (2001) 1.04
Short repeats cause heterogeneity at genomic terminus of bovine herpesvirus 1. J Virol (1986) 1.03
Bovine herpesvirus 1: differentiation of IBR- and IPV-viruses and identification and functional role of their major immunogenic components. Arch Virol (1985) 1.03
Borna virus infections in cattle associated with fatal neurological disease. Vet Rec (1994) 1.03
Staggering disease in cats: isolation and characterization of the feline Borna disease virus. J Gen Virol (1995) 1.02
Bee venom neurotoxin (apamin): iodine labeling and characterization of binding sites. Eur J Biochem (1979) 1.02
Electrophysiological and neurobiochemical evidence for the blockade of a potassium channel by dendrotoxin. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.02